Carie Boyd

Name

Carie Boyd

Legal name

Carie Boyd Pharmaceuticals

Website

https://carieboyd.com

Company type

Private

Founded year

1965

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Irving

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Office-Use Medications (503B): Bulk compounded medications sold to licensed healthcare providers, clinics, hospitals, and group purchasing organizations without patient names or prescriptions. Providers order through customer portal for office administration.
2. Patient-Specific Prescriptions (503A): Compounded medications dispensed pursuant to patient-specific prescriptions from licensed healthcare providers. Medications shipped directly to patients.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Carie Boyd Pharmaceuticals is a compounding pharmaceutical manufacturer operating both an FDA-registered 503B outsourcing facility (Irving, TX) for office-use medications and a 503A specialty compounding pharmacy (Denton, TX) for patient-specific prescriptions. The company compounds bioidentical hormone pellets, injections, oral hormones, topical creams, sublingual formulations, anesthetics, dermatology preparations, sexual wellness products, weight management compounds, and dental and veterinary medications. Its differentiated technology includes an automated pellet manufacturing process with industry-leading potency precision under 1.5% variance, proprietary SubMagna sublingual base for semaglutide, and cGMP-compliant production meeting Title 21 CFR parts 210 and 211 standards.

Product overview

Carie Boyd Pharmaceuticals is a compounding pharmacy offering a diverse portfolio of office-use and patient-specific medications through two facilities: a 503A specialty compounding pharmacy and an FDA-registered 503B outsourcing facility. The product portfolio centers on hormone replacement therapy (HRT) delivered via pellets, injections, oral capsules/tablets, topical creams, and sublingual formulations. Core HRT products include hormone pellets (testosterone, estradiol, testosterone combo), hormone injections (testosterone cypionate, testosterone cypionate/propionate), oral hormones (progesterone and estradiol in various forms), and hormone creams (bi-estrogen, estradiol, estriol, progesterone). Supporting therapies include adjunctive hormone products (anastrozole, clomiphene, DHEA), sexual wellness medications (sildenafil, tadalafil), dermatology/aesthetics preparations, hair/scalp health treatments (Formula 82D/F/M), weight management (semaglutide sublingual, naltrexone), anesthetics (BLT cream, lidocaine products), dental anesthetics, and veterinary medications. Both 503A and 503B operations comply with USP standards and cGMP requirements respectively.

Differentiator

Problem solved

Functional benefit

Products and services

• Hormone Pellets (Estradiol, Testosterone, Testosterone Combo) Subcutaneous implantable bioidentical hormone pellets for healthcare providers and patients needing long-acting hormone replacement therapy; delivers steady hormone release over 3-6 months.
• Hormone Injections (Testosterone Cypionate, Testosterone Cypionate/Propionate) Injectable bioidentical hormone products in multi-dose vials validated for 12 months, intended for healthcare providers and patients requiring injectable hormone therapy.
• Oral Hormones (Progesterone Capsules, Progesterone Sublingual Tablets, Estradiol Sublingual Tablets, Progesterone Troche) Bioidentical oral and sublingual hormone preparations for healthcare providers and patients; available as capsules, sublingual tablets, and troches.
• Hormone Creams (Bi-Estrogen Cream, Estradiol Cream, Estriol Cream, Progesterone Cream) Topical bioidentical hormone creams with 180-day beyond-use date, formulated for healthcare providers and patients who prefer transdermal hormone delivery.
• Adjunctive Hormone Therapy (Anastrozole, Clomiphene, DHEA) Adjunctive hormone therapies for healthcare providers managing patients on primary HRT; available as capsules and drops.
• Sexual Wellness Products (Sildenafil, Tadalafil, Oxytocin, Arousal Cream) Compounded sexual wellness formulations in multiple delivery formats for healthcare providers treating men and women.
• Dermatology & Aesthetics (Hyperpigmentation, Anti-Aging, Rosacea, Acne, Scars, Nail Fungus, Warts, Hyperhidrosis) Prescription-only compounded dermatology preparations for healthcare providers treating a range of skin conditions with customized multi-ingredient formulations.
• Hair & Scalp Health (Formula 82D, 82F, 82M, Dutasteride, Finasteride, Minoxidil/Finasteride) Compounded hair regrowth and scalp health topicals and oral capsules for healthcare providers prescribing hair loss treatments.
• Weight Management (Semaglutide Sublingual, Naltrexone, Bupropion/Naltrexone) Compounded weight management products for healthcare providers, including a proprietary semaglutide sublingual suspension alongside naltrexone and combination capsules.
• Anesthetics (BLT Cream, Sodium Bicarbonate, Lidocaine with Epinephrine) Compounded topical and injectable anesthetics for office-use by healthcare providers across urgent care, surgery, and emergency settings.
• Dental Anesthetics (Profound Gel, Profound Gel Thickened, Profound Gel with Phenylephrine) Compounded dental anesthetic gels and oral pastes in dye-free formulations for dental offices and oral surgery centers.
• Veterinary Medications (EKT Otic, Methimazole, Metronidazole, Doxycycline) Compounded medications for veterinary use, available in customizable strengths and flavors.
• 503B Outsourcing Facility Services FDA-registered 503B outsourcing facility service delivering bulk office-use compounded medications to licensed healthcare providers, clinics, hospitals, and group purchasing organizations without patient-specific prescriptions.
• 503A Compounding Pharmacy Services 503A specialty compounding pharmacy service for patient-specific prescriptions, dispensing personalized compounded medications nationwide from the Denton, TX location with a 2-day standard turnaround.

Quantifiable outcome

• Industry-leading potency variance of less than 1.5% (vs 10% permitted by many compounders)
• +5 more outcomes

Named customers8 records

Segments7 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature4 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Pentec Health: Specialty pharmacy and 503B outsourcing facility providing sterile compounded medications, including intrathecal and parenteral therapies; overlaps with Carie Boyd on provider-channel sterile/non-sterile compounding.
• SottoPelle: Pioneer in subcutaneous hormone pellet therapy for men and women; competes with Carie Boyd's estradiol, testosterone, and testosterone combo pellet products in the same provider-prescribed channel.
• Empower Pharmacy: Largest 503A/503B compounding pharmacy in the United States, offering hormone replacement, weight loss, and sterile injectable compounds; directly comparable to Carie Boyd across business model, customer base (providers and patients), and product mix.
• BioTE Medical: Direct competitor in subcutaneous bioidentical hormone pellet therapy with a national provider training and distribution network; competes head-to-head with Carie Boyd's flagship pellet line.
• QuVa Pharma: 503B outsourcing facility focused on sterile injectable and non-sterile compounded medications for hospitals and clinics; comparable in regulatory posture (cGMP, FDA-registered) and office-use distribution model.
• Avella Specialty Pharmacy: Specialty and compounding pharmacy accredited by URAC and ACHC, offering sterile compounds, HRT, and dermatology preparations; overlaps with Carie Boyd on provider-served patient-specific prescriptions.
• Leiters: FDA-registered 503B outsourcing facility producing sterile and non-sterile compounded medications for hospitals and clinics; comparable in regulatory positioning and provider-channel distribution.
• Olympia Pharmaceuticals: FDA-registered 503B outsourcing facility providing office-use compounded medications to healthcare providers; closely aligned with Carie Boyd's Irving 503B operations in regulatory structure and customer motion.

Broad incumbents

• Fagron: Global leader in pharmaceutical compounding with a broad portfolio of APIs, bases, and compounded products serving both 503A and 503B channels; overlaps with Carie Boyd on HRT, dermatology, and veterinary compounding.

Emerging players

• Wedgewood Pharmacy: Largest US veterinary compounding pharmacy; comparable to Carie Boyd's veterinary line (EKT Otic, methimazole, metronidazole) on formulation expertise and prescriber-channel distribution for animal-health compounds.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/CarieBoydPharma
• LinkedInlinkedin.com/company/carie-boyd-pharmaceuticals
• Instagraminstagram.com/carie_boyd_pharmaceuticals

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carie Boyd